CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPK

被引:25
|
作者
Huang, J. [1 ,2 ]
Shi, T. [1 ,2 ,3 ]
Ma, T. [1 ,2 ]
Zhang, Y. [1 ,2 ]
Ma, X. [1 ,2 ]
Lu, Y. [3 ]
Song, Q. [1 ,2 ]
Liu, W. [1 ,2 ]
Ma, D. [1 ,2 ,3 ]
Qiu, X. [1 ,2 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Lab Med Immunol, Beijing 100871, Peoples R China
[2] Peking Univ, Human Dis Gen Ctr, Beijing 100083, Peoples R China
[3] Chinese Natl Human Genome Ctr, Beijing, Peoples R China
关键词
CCDC134; secretory protein; inhibit; Elk1; MAPK pathway;
D O I
10.1007/s00018-007-7448-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we report a novel gene, CCDC134 (coiled-coil domain containing 134), that encodes a secretory protein that can inhibit the MAPK pathway as a novel human MAPK-regulating protein. The CCDC134 mRNA contains 1280 nucleotides, encoding a protein of 229 amino acids. CCDC134 is a classical secretory protein. Expression profile analysis by Northern blot, RT-PCR, immunohistochemistry and Western blot reveals that CCDC134 is widely expressed in normal adult tissues, tumor tissues and cell lines. Functional investigation reveals that overexpression of CCDC134 and its purified protein significantly inhibit transcriptional activity of Elk1 and phosphorylation of Erk and JNK/SAPK but not p38 MAPK. Conversely, specific siRNA against CCDC134 activates Elk1 transcriptional activity and promotes Erk and JNK/SAPK phosphorylation. These results clearly indicate that CCDC134 is a novel member of the secretory family and down-regulates the Raf-1/MEK/ERK and JNK/ SAPK pathways.
引用
收藏
页码:338 / 349
页数:12
相关论文
共 50 条
  • [21] MCP-1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells
    Werle, M
    Schmal, U
    Hanna, K
    Kreuzer, J
    [J]. CARDIOVASCULAR RESEARCH, 2002, 56 (02) : 284 - 292
  • [22] Phospho-specific mitogen-activated protein kinase antibodies for ERK, JNK, and p38 activation
    Goueli, SA
    Jarvis, BW
    [J]. REGULATORS AND EFFECTORS OF SMALL GTPASES, PT F, RAS FAMILY I, 2001, 332 : 337 - 343
  • [23] Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis
    Stambe, C
    Atkins, RC
    Hill, PA
    Nikolic-Paterson, DJ
    [J]. KIDNEY INTERNATIONAL, 2003, 64 (06) : 2121 - 2132
  • [24] Activation and translocation of MAP kinases p38, JNK and ERK during contact sensitization
    Brand, P
    Plochmann, S
    Knop, J
    Becker, D
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 549 - 549
  • [25] Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells
    Kyaw, M
    Yoshizumi, M
    Tsuchiya, K
    Kirima, K
    Tamaki, T
    [J]. HYPERTENSION RESEARCH, 2001, 24 (03) : 251 - 261
  • [26] Protein phosphatase 2Cα inhibits the human stress-responsive p38 and JNK MAPK pathways
    Takekawa, M
    Maeda, T
    Saito, H
    [J]. EMBO JOURNAL, 1998, 17 (16): : 4744 - 4752
  • [27] Dietary energy restriction inhibits ERK but not JNK or p38 activity in the epidermis of SENCAR mice
    Liu, YH
    Duysen, E
    Yaktine, AL
    Au, A
    Wang, WQ
    Birt, DF
    [J]. CARCINOGENESIS, 2001, 22 (04) : 607 - 612
  • [28] ERK, p38 and JNK MAPK are differently distributed and activated in the anoxic-reogygenated embryonic heart
    Gardier, Stephany
    Pedretti, Sarah
    Sane, Alexandre
    Raddatz, Eric
    [J]. FASEB JOURNAL, 2008, 22
  • [29] Low temperature exposure inhibits proliferation and induces apoptosis of bovine subcutaneous preadipocytes via p38 MAPK/JNK activation
    Li, Tingting
    Bai, Hui
    Yang, Liang
    Hao, Weiguang
    Wei, Shengjuan
    Yan, Peishi
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2023, 264
  • [30] Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma
    Wang, Shen-Nien
    Lee, King-Teh
    Tsai, Chia-Jung
    Chen, Yu-Jie
    Yeh, Yao-Tsung
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (12) : 1295 - 1301